Hen egg-white lysozyme inhibits biological activities of lipopolysaccharides from periodontopathic bacteria

Journal of Periodontal Research

Volumn 32, Issue 3, 1997, Pages 295-299

  Ito, H O ^a   Hirata, M ^a   Koga, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Bacterial lipopolysaccharides; Hen egg white lysozyme; Osteoclasts; Periodontitis

Indexed keywords

ANTITOXIN; EGG PROTEIN; EGG WHITE; LIPOPOLYSACCHARIDE; LYSOZYME;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMAL; ARTICLE; CELL DIFFERENTIATION; CHEMISTRY; CHICKEN; DRUG ANTAGONISM; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; HUMAN; LIMULUS LYSATE TEST; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; MOUSE; OSTEOCLAST; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PROTEIN BINDING;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMALS; ANTITOXINS; CELL DIFFERENTIATION; CHICKENS; EGG PROTEINS; EGG WHITE; GRAM-NEGATIVE BACTERIA; HUMANS; LIMULUS TEST; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MURAMIDASE; OSTEOCLASTS; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PROTEIN BINDING;

EID: 0031114599     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1997.tb00537.x     Document Type: Article

References (27)

1. Smith-Gill SJ, Sercarz EE. The immune response to structurally defined proteins: the lysozyme model. New York: Adenine Press, 1989.
2. Ohno N, Morrison DC. Lipopolysaccharide interaction with lysozyme. Binding of lipopolysaccharide to lysozyme and inhibition of lysozyme enzymatic activity. J Biol Chem 1989; 264: 4434-4441.
3. Ohno N, Momson DC. Lipopolysaccharide interactions with lysozyme differentially affect lipopolysaccharide immunostimulatory activity. Eur J Biochem 1989; 186: 629-636.
4. Takada K, Ohno N, Yadomae T. Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo. Infect Immun 1994; 62: 1171-1175.
5. Socransky SS, Haffajee AD. Effect of therapy on periodontal infections. J Periodontol 1993; 64: 754-759.
6. Hamada S, Takada H, Ogawa T, Fujiwara T, Mihara J. Lipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties. Int Rev Immunol 1990; 6: 247-261.
7. Masoud H, Weintraub ST, Wang R, Cotter R, Holt SC. Investigation of the structure of lipid A from Actinobacillus actinomycetemcomitans strain Y4 and human clinical isolate PO 1021-7. Eur J Biochem 1991; 200: 775-781.
8. Takada H, Mihara J, Morisaki I, Hamada S. Induction of interleukin-1 and -6 in human gingival fibroblast cultures stimulated with Bacteroides lipopolysaccharides. Infect Immun 1991; 59: 295-301.
9. Tamura M, Tokuda M, Nagaoka S, Takada H. Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures. Infect Immun 1992; 60: 4932-4937.
10. Iino Y, Hopps RM. The bone-resorbing activities in tissue culture of lipopolysaccharides from the bacteria Actinobacillus actinomycetemcomitans, Bacteroides gingivalis, and Capnocytophaga ochracea isolated from human mouths. Arch Oral Biol 1984; 29: 59-63.
11. Millar SJ, Goldstein EG, Levine MJ, Hausmann E. Modulation of bone metabolism by two chemically distinct lipopolysaccharide fractions from Bacteroides gingivalis. Infect Immun 1986; 51: 302-306.
12. Nishihara T, Ohsaki Y, Ueda N, Saito N, Mundy GR. Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation. Infect Immun 1994; 62: 390-397.
13. Ito H-O, Shuto T, Takada H, et al. Lipopolysaccharides from Porphyromonas gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans promote osteoclastic differentiation. Arch Oral Biol 1996; 41: 439-444.
14. Takada H, Hirai H, Fujiwara T, Koga T, Ogawa T, Hamada S. Bacteroides lipopolysaccharides (LPS) induce anaphylactoid and lethal reactions in LPS-responsive and -non responsive mice primed with muramyl dipeptide. J Infect Dis 1990; 162: 428-434.
15. Koga T, Nishihara T, Amano K, et al. Chemical and biological properties of cell-surface components of Actinobacillus actinomycetemcomitans. In: Hamada S, Holt SC, McGhee JR, eds. Periodontal disease: pathogenesis and host immune responses. Tokyo: Quintessence, 1991; 117-127.
16. Westphal O, Jann K. Bacterial lipopolysaccharide. Extraction with phenol-water and further applications of the procedure. Meth Carbohydr Chem 1965; 5: 83-91.
17. Takada H, Kawabata Y, Tamura M, et al. Cytokine induction by extracellular products of oral viridans group streptococci. Infect Immun 1993; 61: 5252-5260.
18. Ito H, Harada Y, Matsuo T, Ebisu S, Okada H. Possible role of T cells in the establishment of IgG plasma cell-rich periodontal lesion - augmentation of IgG synthesis in the polyclonal B cell activation response by autoreactive T cells. J Periodont Res 1988; 23: 39-45.
19. Asakura K, Kojima T, Shirasaki H, Kataura A. Evaluation of the effects of antigen specific immunotherapy on chronic sinusitis in children with allergy. Auris Nasus Larynx 1990; 17: 33-38.
20. Ishikawa I, Okada H, Kamoi K, et al. Clinical evaluation of lysozyme chloride on marginal periodontitis using double-blind comparative study. J Jpn Soc Periodont 1992; 34: 883-900.
21. Sugai S, Ikeguchi M. Conformational comparison between alpha-lactalbumin and lysozyme. Adv Biophys 1994; 30: 37-84.
22. Hausmann E, Raisz LG, Miller WA. Endotoxin: stimulation of bone resorption in tissue culture. Science 1970; 168: 862-864.
23. Ohno N, Tanida N, Yadomae T. Characterization of complex formation between lipopolysaccharide and lysozyme. Carbohydrate Res 1991; 214: 115-30.
24. Rifkind D. Prevention by polymyxin B of endotoxin lethality in mice. J Bacterial 1967; 93: 1463-1464.
25. Greenman RL, Schein RM, Martin MA, et al. A controlled clinical trial of ES murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative sepsis. The XOMA Sepsis Study Group. JAMA 1991; 266: 1097-1102.
26. Ziegler EJ, Fisher CJ, Sprung CL, et al. Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 1991; 324: 429-436.
27. Lynn WA, Golenbock DT. Lipopolysaccharide antagonists. Immunol Today 1992; 13: 271-276.